Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Wound Care ; 26(4): 168-177, 2017 Apr 02.
Article in English | MEDLINE | ID: mdl-28379095

ABSTRACT

OBJECTIVE: There is an increasing search for antibiofilm agents that either have specific activity against biofilms or may act in synergy with antimicrobials. Our objective is to examine the the antibiofilm properties of stingless bee honeys. METHOD: Meliponini honeys from Costa Rica were examined along with Medihoney as a reference. All honeys were submitted to a screening composed of minimum inhibitory concentration, inhibition of biofilm formation and biofilm destruction microplate-based assays against a Staphylococcus aureus biofilm forming strain. Dialysis led to the isolation of an antibiofilm fraction in Tetragonisca angustula honeys. The honey antibiofilm fraction was evaluated for protease activity and for any synergistic effect with antibiotics on a Staphylococcus aureus biofilm. The active fraction was then separated through activity guided isolation techniques involving SDS-PAGEs, anion exchange and size exclusion fast protein liquid chromatographies. The fractions obtained and the isolated antibiofilm constituents were tested for amylase and DNase activity. RESULTS: A total of 57 Meliponini honeys from Costa Rica were studied in this research. The honeys studied belonged to the Tetragonisca angustula (n=36) and Melipona beecheii (n=21) species. Costa Rican Tetragonisca angustula honeys can inhibit the planktonic growth, biofilm formation, and are capable of destroying a Staphylococcus aureus biofilm. The antibiofilm effect was observed in the protein fraction of Tetragonisca angustula honeys. The biofilm destruction proteins allowed ampicillin and vancomycin to recover their antimicrobial activity over a Staphylococcus aureus biofilm. The antibiofilm proteins are of bee origin, and their activity was not due to serine, cysteine or metalloproteases. There were 2 proteins causing the antibiofilm action; these were named the Tetragonisca angustula biofilm destruction factors (TABDFs). TABDF-1 is a monomeric protein of approximately 50kDa that is responsible of the amylase activity of Tetragonisca angustula honeys. TABDF-2 is a protein monomer of approximately 75kDa. CONCLUSION: Tetragonisca angustula honeys from Costa Rica are a promising candidate for research and development of novel wound dressings focused on the treatment of acute and chronic Staphylococcus aureus biofilm wound infections.


Subject(s)
Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Honey , Staphylococcus aureus/drug effects , Ampicillin/pharmacology , Amylases , Animals , Bees , Costa Rica , Deoxyribonucleases , Microbial Sensitivity Tests , Staphylococcus aureus/growth & development , Vancomycin/pharmacology
2.
J Wound Care ; 17(4): 172-4, 176-8, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18494436

ABSTRACT

OBJECTIVE: Hydroxyl radical and hypochlorite anion formed at the wound site from superoxide anion produced by activated polymorphonuclear neutrophils (PMNs) are considered important factors in impaired wound healing. Superoxide anion may also react with nitric oxide produced by macrophages to form peroxynitrite, a third strong oxidant that damages surrounding tissue. In order to select honey for use in wound-healing products, different samples were compared for their capacity to reduce levels of reactive oxygen species (ROS) in vitro. METHOD: Honey samples were tested in assays for inhibition of ROS production by activated human PMNs, antioxidant activity (scavenging of superoxide anion in a cell-free system) and inhibition of human complement (reducing levels of ROS by limiting formation of complement factors that attract and stimulate PMNs). For buckwheat honey (NewYork, US), moisture and free acid content were determined by refractive index measurement and potentiometric titration respectively. Honey constituents other than sugars were investigated by thin layer chromatography, using natural product reagent to detect phenolic compounds. Constituents with antioxidant properties were detected by spraying the chromatogram with DPPH. RESULTS: Although most honey samples were shown to be active, significant differences were observed, with the highly active honey exceeding the activities of samples with minor effects by factors of 4 to 30. Most pronounced activities were found for American buckwheat honey from the state of NewYork. Phenolic constituents of buckwheat honey were shown to have antioxidant activity. CONCLUSION: As buckwheat honey was most effective in reducing ROS levels, it was selected for use in wound-healing products. The major antioxidant properties in buckwheat honey derive from its phenolic constituents, which are present in relatively large amounts. Its phenolic compounds may also exert antibacterial activity, whereas its low pH and high free acid content may assist wound healing.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Fagopyrum , Free Radical Scavengers/therapeutic use , Honey , Wound Healing , Wounds and Injuries/prevention & control , Anti-Inflammatory Agents/pharmacology , Biological Assay , Chromatography, Thin Layer , Complement System Proteins/drug effects , Complement System Proteins/physiology , Drug Evaluation, Preclinical , Free Radical Scavengers/pharmacology , Honey/analysis , Humans , Hydrogen-Ion Concentration , Lipid Peroxidation/drug effects , Lipid Peroxidation/physiology , Macrophages/drug effects , Macrophages/physiology , Neutrophils/drug effects , Neutrophils/physiology , Nitric Oxide/adverse effects , Nitric Oxide/analysis , Peroxynitrous Acid/adverse effects , Peroxynitrous Acid/analysis , Pilot Projects , Reactive Oxygen Species/adverse effects , Reactive Oxygen Species/analysis , Skin Care/methods , Superoxides/adverse effects , Superoxides/analysis , Wound Healing/drug effects , Wound Healing/physiology , Wounds and Injuries/immunology , Wounds and Injuries/metabolism
3.
Burns ; 34(6): 845-55, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18378399

ABSTRACT

A liposomal hydrogel with 3% povidone-iodine (PVP-ILH, Repithel) has shown clinical benefit in settings where inflammation and/or reactive oxygen species are thought to impede wound healing (e.g., burns, chronic wounds and in smokers). This in vitro study investigated whether PVP-ILH is able to reduce inflammatory events responsible for the impairment of the wound healing process in such patients. Therefore, the following assays were conducted with PVP-ILH (and derived control hydrogels to identify the component responsible for the effect): inhibition of reactive oxygen species production by human polymorphonuclear neutrophils (PMNs) and in a cell-free system, oxygen consumption assay of PMNs (prior to oxidative burst), inhibition of human complement (limiting the generation of complement factors), mast cell degranulation, nitric oxide production by murine macrophages and TNF-alpha production by human monocytes/macrophages. Where toxicity could cause cell inhibition, cell viability was assessed. PVP-ILH and its components interacted in our series of bioassays at various stages in the inflammation cascade. Scavenging of superoxide anions was the most pronounced effect. Furthermore, povidone-iodine inhibited PMN production of reactive oxygen species (inhibition of oxygen consumption) and a mast cell inhibitory (stabilising) activity was observed. Based on these results, the clinically observed, beneficial wound healing effects of PVP-ILH may also be attributed to an impediment of inflammatory activity, mainly by iodine's free radical scavenging. Controlling oxidative stress in the wound may be of great importance, especially since further reactions as, e.g., the formation of peroxynitrite from NO and ROS are prevented.


Subject(s)
Anti-Infective Agents, Local/therapeutic use , Povidone-Iodine/therapeutic use , Skin/injuries , Wound Healing/drug effects , Absorption , Administration, Topical , Animals , Humans , Hydrogel, Polyethylene Glycol Dimethacrylate/administration & dosage , Hydrogels/pharmacology , Liposomes , Povidone-Iodine/administration & dosage , Reactive Oxygen Species/metabolism , Wound Healing/physiology , Wound Infection/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...